Coronary Artery and Peripheral Vascular Disease in a Patient with Poorly Differentiated Thyroid Cancer Treated with the Tyrosine Kinase Inhibitor Lenvatinib

Autor: Vineeth Sukrithan, Lisa Kim, Jennifer A. Sipos, Ashima Goyal, Ye Zhou, Daniel Addison, Manisha Shah, Bhavana Konda, Ajay Vallakati

Publikováno v: Case Reports in Endocrinology, Vol 2023 (2023)

A subset of patients with differentiated thyroid carcinoma develop radioiodine refractory (RAIR) incurable disease, which typically has a poor prognosis. The multitargeted tyrosine kinase inhibitor lenvatinib has demonstrated significant improvements

Externí odkaz: https://doaj.org/article/4337e1f4ed4b4dcfab351e697d0c32a1

Dabrafenib Versus Dabrafenib + Trametinib inlt;igt;BRAFlt;/igt;-Mutated Radioactive Iodine Refractory Differentiated Thyroid Cancer: Results of a Randomized, Phase 2, Open-Label Multicenter Trial

Autor: Naifa L. Busaidy, Bhavana Konda, Lai Wei, Lori J. Wirth, Catherine Devine, Gregory A. Daniels, Jonas A. DeSouza, Ming Poi, Nathan D. Seligson, Maria E. Cabanillas, Jennifer A. Sipos, Matthew D. Ringel, Ann-Kathrin Eisfeld, Cynthia Timmers, Manisha H. Shah

Publikováno v: Thyroid : official journal of the American Thyroid Association. 32(10)

lt;bgt;lt;igt;Background:lt;/igt;lt;/bgt; Oncogenic BRAF mutations are commonly found in advanced differentiated thyroid cancer (DTC), and reports have shown efficacy of BRAF inhibitors in these tumors. We investigated the difference in response betw

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c23df625f9d2460f3b04a8b48c5304a1
https://pubmed.ncbi.nlm.nih.gov/35658604

Thyroid-optimized and thyroid-sparing radiotherapy in oral cavity and oropharyngeal carcinoma: A dosimetric study

Autor: Wesley Zoller, V.M. Diavolitsis, Ghazal Khandel, Eric D. Miller, M.Z. Kharouta, Jennifer A. Sipos, Dukagjin Blakaj, John C. Grecula, Jacob Eckstein, Ashlee Ewing, E. Healy, Jessica Wobb, Mauricio E. Gamez, Sachin R. Jhawar, Aashish D. Bhatt, Anna K. Wu, Stella Ling, N. Damico, Alok Deshane, D.L. Mitchell

Publikováno v: Technical Innovations & Patient Support in Radiation Oncology, Vol 20, Iss, Pp 28-34 (2021)
Technical Innovations & Patient Support in Radiation Oncology

Highlights • This feasibility study showed thyroid sparing in head and neck cancer patients. • Thyroid sparing with acceptable target volume coverage was possible with IMRT. • Average mean dose to thyroid was significantly reduced with thyroid

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed50c1ef8a8e0b00813f13f42f11e8af
http://www.sciencedirect.com/science/article/pii/S2405632421000378

Prevalence of cancer and the benign call rate of afirma gene classifier in 18F‐Fluorodeoxyglucose positron emission tomography positive cytologically indeterminate thyroid nodules

Autor: Lawrence A. Shirley, Clarine Long, Chadwick Wright, Mayumi Endo, Katie Roll, Haikady N. Nagaraja, Fadi Nabhan, Jennifer A. Sipos, Kyle Porter, John E. Phay, Matthew D. Ringel

Publikováno v: Cancer Medicine, Vol 10, Iss 3, Pp 1084-1090 (2021)
Cancer Medicine

Background 18 F‐Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) positive (PET+) cytologically indeterminate thyroid nodules (ITNs) have variable cancer risk in the literature. The benign call rate (BCR) of Afirma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4edbc1a739b442ed30726d45d022583e
https://doaj.org/article/494680436bc04eb78d57252000a7e31f

The future of thyroid nodule risk stratification

Autor: Nydia Burgos, Naykky Singh Ospina, Jennifer A. Sipos

Publikováno v: Endocrinol Metab Clin North Am

Clinical evidence supports the association of ultrasound features with benign or malignant thyroid nodules and serves as the basis for sonographic stratification of thyroid nodules, according to an estimated thyroid cancer risk. Contemporary guidelin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e03364f736ca21053d7614e6cea5e4b
https://europepmc.org/articles/PMC10314730/